Relievant Medsystems Obtains $30,000,000 Series D Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5391ef10-a91d-485c-a3c0-623ecc0455d8&Preview=1 - Date
3/28/2012 - Company Name
Relievant Medsystems - Mailing Address
2688 Middlefield Road Redwood City, CA 94063 - Company Description
Relievant MedSystems is a medical device company developing novel products to treat lower back pain using a minimally invasive therapeutic approach. The company was founded in 2004 and is headquartered in San Francisco, California. - Website
http://www.relievant.com - Transaction Type
Venture Equity - Transaction Amount
$30,000,000 - Transaction Round
Series D - Proceeds Purposes
Proceeds from this financing will enable Relievant to accelerate execution of our landmark SMART Clinical Trial and to conduct additional clinical studies for the Intracept Ablation System. These studies are key drivers for our plan to continue advancing the utility of basivertebral nerve ablation for isolated axial low back pain and to successfully commercialize Intracept worldwide. - M&A Terms
- Venture Investor
New Enterprise Associates - Venture Investor
Canaan Partners - Venture Investor
Emergent Medical Partners - Venture Investor
Morgenthaler Ventures - Venture Investor
ONSET Ventures
